UnitedHealth Group Incorporated (NYSE:UNH) Shares Acquired by RDA Financial Network

RDA Financial Network increased its position in UnitedHealth Group Incorporated (NYSE:UNH) by 10.1% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 8,503 shares of the healthcare conglomerate’s stock after buying an additional 778 shares during the quarter. UnitedHealth Group comprises about 1.4% of RDA Financial Network’s investment portfolio, making the stock its 14th biggest position. RDA Financial Network’s holdings in UnitedHealth Group were worth $4,206,000 at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in the company. Orser Capital Management LLC raised its position in UnitedHealth Group by 128.4% in the first quarter. Orser Capital Management LLC now owns 1,028 shares of the healthcare conglomerate’s stock valued at $509,000 after purchasing an additional 578 shares during the period. Cooper Financial Group increased its position in shares of UnitedHealth Group by 8.0% during the first quarter. Cooper Financial Group now owns 2,239 shares of the healthcare conglomerate’s stock worth $1,108,000 after acquiring an additional 165 shares during the last quarter. Salem Investment Counselors Inc. increased its position in shares of UnitedHealth Group by 7.8% during the first quarter. Salem Investment Counselors Inc. now owns 38,702 shares of the healthcare conglomerate’s stock worth $19,146,000 after acquiring an additional 2,796 shares during the last quarter. Unique Wealth LLC grew its stake in UnitedHealth Group by 30.8% in the first quarter. Unique Wealth LLC now owns 2,869 shares of the healthcare conglomerate’s stock worth $1,427,000 after purchasing an additional 676 shares in the last quarter. Finally, International Assets Investment Management LLC increased its holdings in shares of UnitedHealth Group by 58.1% in the first quarter. International Assets Investment Management LLC now owns 7,062 shares of the healthcare conglomerate’s stock valued at $3,458,000 after buying an additional 2,594 shares in the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Trading Up 0.4 %

UNH opened at $484.57 on Monday. The stock has a market capitalization of $445.99 billion, a P/E ratio of 29.50, a P/E/G ratio of 1.41 and a beta of 0.58. The firm’s fifty day simple moving average is $497.01 and its 200 day simple moving average is $503.62. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $554.70. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.69.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, beating analysts’ consensus estimates of $6.63 by $0.28. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The business had revenue of $99.80 billion for the quarter, compared to analyst estimates of $99.23 billion. During the same quarter in the prior year, the business earned $6.26 EPS. UnitedHealth Group’s quarterly revenue was up 8.6% on a year-over-year basis. As a group, research analysts anticipate that UnitedHealth Group Incorporated will post 27.57 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 25th. Shareholders of record on Monday, June 17th will be issued a $2.10 dividend. The ex-dividend date is Monday, June 17th. This represents a $8.40 dividend on an annualized basis and a yield of 1.73%. This is an increase from UnitedHealth Group’s previous quarterly dividend of $1.88. UnitedHealth Group’s payout ratio is currently 51.34%.

Wall Street Analysts Forecast Growth

UNH has been the topic of several research analyst reports. TD Cowen lowered their price objective on shares of UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating on the stock in a research report on Wednesday, April 10th. JPMorgan Chase & Co. lifted their price objective on shares of UnitedHealth Group from $546.00 to $559.00 and gave the stock an “overweight” rating in a research report on Thursday, May 30th. Truist Financial restated a “buy” rating and set a $600.00 price target on shares of UnitedHealth Group in a report on Wednesday, April 17th. Royal Bank of Canada lowered their price target on shares of UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating on the stock in a report on Wednesday, April 17th. Finally, Wells Fargo & Company decreased their price objective on shares of UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating for the company in a report on Monday, April 8th. Three research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $579.74.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.